Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (17)

  1. Serge Perrot, Anne-Priscille Trouvin. Cannabis for musculoskeletal pain and arthritis: Evidence is needed. Joint Bone Spine 2019;86:1
  2. Nathan Herrmann, Myuri Ruthirakuhan, Damien Gallagher, Nicolaas Paul L.G. Verhoeff, Alex Kiss, Sandra E. Black, Krista L. Lanctôt. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. The American Journal of Geriatric Psychiatry 2019;27:1161
  3. Douglas E. Brenneman, Dean Petkanas, William A. Kinney. Pharmacological Comparisons Between Cannabidiol and KLS-13019. J Mol Neurosci 2018;66:121
  4. Andrea Mastinu, Marika Premoli, Giulia Ferrari-Toninelli, Simone Tambaro, Giuseppina Maccarinelli, Maurizio Memo, Sara Anna Bonini. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. 2018;36
  5. Sara Anna Bonini, Marika Premoli, Simone Tambaro, Amit Kumar, Giuseppina Maccarinelli, Maurizio Memo, Andrea Mastinu. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology 2018;227:300
  6. Per Damkier, Dorte Lassen, Mette Marie Hougaard Christensen, Kenneth Grønkjaer Madsen, Maja Hellfritzsch, Anton Pottegård. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol 2019;124:28
  7. Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam, Victor Novack. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine 2018;49:44
  8. Amir Minerbi, Winfried Häuser, Mary-Ann Fitzcharles. Medical Cannabis for Older Patients. Drugs Aging 2019;36:39
  9. Anthony M. Downs, Kaitlyn M. Roman, Simone A. Campbell, Antonio Pisani, Ellen J. Hess, Paola Bonsi. The neurobiological basis for novel experimental therapeutics in dystonia. Neurobiology of Disease 2019;130:104526
  10. Sarah Pirio Richardson, H. A. Jinnah. New approaches to discovering drugs that treat dystonia. Expert Opinion on Drug Discovery 2019;14:893
  11. . Individualize treatment when prescribing medical cannabis to older patients as efficacy data remains limited. Drugs Ther Perspect 2019;35:486
  12. Serge Perrot, Anne-Priscille Trouvin. Le cannabis dans les douleurs musculosquelettiques et articulaires : des preuves sont nécessaires. Revue du Rhumatisme 2019;86:215
  13. Douglas E. Brenneman, William A. Kinney, Sara Jane Ward. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity. J Mol Neurosci 2019;68:603
  14. A.-P. Trouvin, S. Perrot. Cannabis : enjeux et risques en médecine de la douleur. Douleur analg 2019;32:73
  15. Renata Rizzo, Mariangela Gulisano. Treatment Resistance in Psychiatry. 2019.
  16. Hillary D. Lum, Kanika Arora, J. Alton Croker, Sara H. Qualls, Melissa Schuchman, Julie Bobitt, Gary Milavetz, Brian Kaskie. Patterns of Marijuana Use and Health Impact: A Survey Among Older Coloradans. Gerontology and Geriatric Medicine 2019;5:233372141984370
  17. Jodie Belinda Hillen, Natalie Soulsby, Chris Alderman, Gillian E. Caughey. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Therapeutic Advances in Drug Safety 2019;10:204209861984699